Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Vein of Marshall Ethanol Infusion for Persistent Atrial Fibrillation (VOM-R01)

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2016 by The Methodist Hospital System
Sponsor:
Collaborators:
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
The Methodist Hospital System
Information provided by (Responsible Party):
Miguel X. Valderrabano, MD, The Methodist Hospital System
ClinicalTrials.gov Identifier:
NCT01898221
First received: May 28, 2013
Last updated: September 13, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2020
  Estimated Primary Completion Date: December 2019 (Final data collection date for primary outcome measure)